The aim of this working group is to identify and prioritize symptom domains that should be consistently evaluated in Sjögren’s clinical trials, and to identify aspects of domains and outcome measures that should be part of a concerted research agenda. Such an effort will help standardize and improve the quality of outcomes, research and ultimately treatment for patients.
To accomplish these aims, OMERACT utilizes a data driven, iterative consensus process, which is facilitated by participants within the working group. Participants provide input on the development of research agendas, which focus on measurement issues and take into consideration:
Visit the OMERACT website to learn more about this important work.
OMERACT (Outcome Measures in Rheumatology) is an independent initiative of international health professionals and patient research partners interested in outcome measures and measurement methodology, especially in rheumatology.